Figures & data
![](/cms/asset/ee6f7a43-7134-4ecf-969c-c1d7fb2bf2ac/dppa_a_12178416_uf0001_b.jpg)
Table 1 Pre-specified definitions used for sampling variation
Box 1 Topic list
Table 2 Demographic and background characteristics (N=18 patients with severe hemophilia)
Figure 1 Decision making concerning prophylaxis adherence among AYAs: Treatment responsibility and estimating bleeding risk.
Notes: Phase 1: parents took responsibility for their prophylactic treatment and performed bleeding management phase 2 and 3 increased self-management causing considerations concerning adherence
![Figure 1 Decision making concerning prophylaxis adherence among AYAs: Treatment responsibility and estimating bleeding risk.Notes: Phase 1: parents took responsibility for their prophylactic treatment and performed bleeding management phase 2 and 3 increased self-management causing considerations concerning adherence](/cms/asset/997ae5f7-c1fa-40be-b894-9ec0850f7e30/dppa_a_12178416_f0001_c.jpg)
Table 3 Quotes explaining adherence to prophylactic treatment in adolescents with hemophilia